Relafen 750, pharmacologically known as this compound potassium, presents a unique case from a biochemical perspective . Its mechanism of action primarily involves the inhibition of cyclooxygenase enzymes , specifically COX-2, resulting in a reduction in prostaglandin production . This process effectively diminishes soreness and redness associated